95 related articles for article (PubMed ID: 36768994)
1. DNA Damage Response Gene Signature as Potential Treatment Markers for Oral Squamous Cell Carcinoma.
Pomella S; Cassandri M; Melaiu O; Marampon F; Gargari M; Campanella V; Rota R; Barillari G
Int J Mol Sci; 2023 Jan; 24(3):. PubMed ID: 36768994
[TBL] [Abstract][Full Text] [Related]
2. Comparing Genomic Landscapes of Oral and Cutaneous Squamous Cell Carcinoma of the Head and Neck: Quest for Novel Diagnostic Markers.
Gupta R; Strbenac D; Satgunaseelan L; Cheung VK; Narayanappa H; Ashford B; Mitchell J; Thind A; Palme CE; Ch'ng S; Low TH; Wykes J; Willet CE; Chew T; Yang J; Ranson M; Clark JR
Mod Pathol; 2023 Aug; 36(8):100190. PubMed ID: 37080394
[TBL] [Abstract][Full Text] [Related]
3. Identification of potential druggable targets of cell cycle with small-molecule inhibitors in oral squamous cell carcinoma.
Zhou X; Jin W; Chen Y; Zhu L; Mo A; Xie Q
Pharmacogenet Genomics; 2022 Jun; 32(4):125-137. PubMed ID: 34954767
[TBL] [Abstract][Full Text] [Related]
4. Integration of transcriptomics and metabolomics reveals a novel gene signature guided by FN1 associated with immune response in oral squamous cell carcinoma tumorigenesis.
Peng Y; Yin D; Li X; Wang K; Li W; Huang Y; Liu X; Ren Z; Yang X; Zhang Z; Zhang S; Fan T
J Cancer Res Clin Oncol; 2023 Aug; 149(9):6097-6113. PubMed ID: 36656379
[TBL] [Abstract][Full Text] [Related]
5. Expression profiling of signal transducer and activator of transcription3 in oral squamous cell carcinoma in south Indian population.
Thomas P; Selvakumar SC; Preethi KA; Sekar D
Minerva Dent Oral Sci; 2024 Feb; 73(1):37-44. PubMed ID: 37878241
[TBL] [Abstract][Full Text] [Related]
6. Genome-wide CRISPR screens of oral squamous cell carcinoma reveal fitness genes in the Hippo pathway.
Chai AWY; Yee PS; Price S; Yee SM; Lee HM; Tiong VK; Gonçalves E; Behan FM; Bateson J; Gilbert J; Tan AC; McDermott U; Garnett MJ; Cheong SC
Elife; 2020 Sep; 9():. PubMed ID: 32990596
[TBL] [Abstract][Full Text] [Related]
7. The role of non-coding RNAs in drug resistance of oral squamous cell carcinoma and therapeutic potential.
Meng X; Lou QY; Yang WY; Wang YR; Chen R; Wang L; Xu T; Zhang L
Cancer Commun (Lond); 2021 Oct; 41(10):981-1006. PubMed ID: 34289530
[TBL] [Abstract][Full Text] [Related]
8. Construction and validation of a metabolic-related genes prognostic model for oral squamous cell carcinoma based on bioinformatics.
Zhang J; Ma C; Qin H; Wang Z; Zhu C; Liu X; Hao X; Liu J; Li L; Cai Z
BMC Med Genomics; 2022 Dec; 15(1):269. PubMed ID: 36566175
[TBL] [Abstract][Full Text] [Related]
9. Genomic and Transcriptomic Landscape of an Oral Squamous Cell Carcinoma Mouse Model for Immunotherapy.
Lee YM; Hsu CL; Chen YH; Ou DL; Hsu C; Tan CT
Cancer Immunol Res; 2023 Nov; 11(11):1553-1567. PubMed ID: 37669022
[TBL] [Abstract][Full Text] [Related]
10. Development of a novel senescence-related gene signature to predict clinical outcomes, immune landscape, and chemotherapeutic sensitivity in oral squamous cell carcinoma.
Wang A; Xiao N; Wang H; Yao Q; Li J; Wu Y; Ge H; Diao P
Head Neck; 2024 May; 46(5):1112-1125. PubMed ID: 38380567
[TBL] [Abstract][Full Text] [Related]
11. Copy Number Variation That Influences the Ionizing Radiation Sensitivity of Oral Squamous Cell Carcinoma.
Izumi T; Rychahou P; Chen L; Smith MH; Valentino J
Cells; 2023 Oct; 12(20):. PubMed ID: 37887269
[TBL] [Abstract][Full Text] [Related]
12. Identification of Somatic Mutations in Plasma Cell-Free DNA from Patients with Metastatic Oral Squamous Cell Carcinoma.
Lin LH; Chang KW; Cheng HW; Liu CJ
Int J Mol Sci; 2023 Jun; 24(12):. PubMed ID: 37373553
[TBL] [Abstract][Full Text] [Related]
13. Identification of key gene signatures and their characterization by expression correlation with drug sensitivity in smoking-associated oral squamous cell carcinoma.
Gollapalli P; Alagundagi D; Ghate SD; Shetty VV; Shetty P; Patil P
J Cancer Res Ther; 2023 Oct; 19(7):1743-1752. PubMed ID: 38376273
[TBL] [Abstract][Full Text] [Related]
14. A surprising cross-species conservation in the genomic landscape of mouse and human oral cancer identifies a transcriptional signature predicting metastatic disease.
Onken MD; Winkler AE; Kanchi KL; Chalivendra V; Law JH; Rickert CG; Kallogjeri D; Judd NP; Dunn GP; Piccirillo JF; Lewis JS; Mardis ER; Uppaluri R
Clin Cancer Res; 2014 Jun; 20(11):2873-84. PubMed ID: 24668645
[TBL] [Abstract][Full Text] [Related]
15. Increased V-ATPase activity can lead to chemo-resistance in oral squamous cell carcinoma via autophagy induction: new insights.
Lagzian A; Askari M; Haeri MS; Sheikhi N; Banihashemi S; Nabi-Afjadi M; Malekzadegan Y
Med Oncol; 2024 Apr; 41(5):108. PubMed ID: 38592406
[TBL] [Abstract][Full Text] [Related]
16. New insights into redox-related risk factors and therapeutic targets in oral squamous cell carcinoma.
Dewenter I; Kumbrink J; Poxleitner P; Smolka W; Liokatis P; Fliefel R; Otto S; Obermeier KT
Oral Oncol; 2023 Dec; 147():106573. PubMed ID: 37951115
[TBL] [Abstract][Full Text] [Related]
17. Spatial transcriptomics reveals distinct and conserved tumor core and edge architectures that predict survival and targeted therapy response.
Arora R; Cao C; Kumar M; Sinha S; Chanda A; McNeil R; Samuel D; Arora RK; Matthews TW; Chandarana S; Hart R; Dort JC; Biernaskie J; Neri P; Hyrcza MD; Bose P
Nat Commun; 2023 Aug; 14(1):5029. PubMed ID: 37596273
[TBL] [Abstract][Full Text] [Related]
18. Novel therapeutic inhibitors for oral squamous cell cancer (OSCC) from seaweeds.
Kannan K; Pitchiah S; E D; Ramasamy P
Eur J Surg Oncol; 2023 May; 49(5):1048-1049. PubMed ID: 36702714
[No Abstract] [Full Text] [Related]
19. The potential role of COVID-19 in progression, chemo-resistance, and tumor recurrence of oral squamous cell carcinoma (OSCC).
Norouzi A; Liaghat M; Bakhtiyari M; Noorbakhsh Varnosfaderani SM; Zalpoor H; Nabi-Afjadi M; Molania T
Oral Oncol; 2023 Sep; 144():106483. PubMed ID: 37421672
[TBL] [Abstract][Full Text] [Related]
20. The Neem Limonoid Nimbolide Modulates Key Components of the DNA Damage Response Signalling in Cellular and Animal Models of Oral Squamous Cell Carcinoma.
Arvindh S; Priyadarshini M; Baba AB; Veeravarmal V; Mishra R; Dash R; Nagini S
Curr Pharm Biotechnol; 2024 Mar; ():. PubMed ID: 38561609
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
